Johnson & Johnson is a holding company. The Company and its subsidiaries are engaged in the research and development, manufacture and sale of a range of products in the health care field. It has more than 250 operating companies conducting business worldwide. The Company’s operating companies are organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Company and its subsidiaries operate 139 manufacturing facilities occupying approximately 21.8 million square feet of floor space. Within the United States, 7 facilities are used by the Consumer segment, 11 by the Pharmaceutical segment and 36 by the Medical Devices and Diagnostics segment (More on Reuters).
Here are some Fundamental Figures:
Sales | 62.13 Bil |
Income | 12.28 Bil |
Net Profit Margin | 19.77% |
Return on Equity | 21.78% |
Debt/Equity Ratio | 0.3 |
Revenue/Share | 22.32 |
Earnings/Share | 4.41 |
Book Value/Share | 21.86 |
Dividend Rate | 2.28 |
Payout Ratio | 48.00% |
Here are some Pricing Figures:
Price/Earnings | 14.8 |
Price/Book | 3 |
Price/Sales | 2.9 |
Price/Cash Flow | 12.1 |
Dividend Yield % | 3.49 |
Forward Price/Earnings | 12.4 |
PEG Ratio | 2 |
PEG Payback (Yrs) | 8.4 |
Here are some Trading Figures:
Last Price | 65.25 |
52-Wk High | 67.37 |
52-Wk Low | 56.86 |
Volume | NA |
Avg Daily Vol (13 Wks) | 12.35 Mil |
50-Day Moving Average | 65.68 |
200-Day Moving Average | 62.72 |
Volatility (beta) | 0.61 |
 |
| Sales and Income Figures of Johnson&Johnson (Click to enlarge) |
Do you have further dividend ideas you want to share with our audience? Please contact us and submit your stock idea here: dividendyields@googlemail.com